This inventor holds 1 USPTO granted patent. Active years: 2026.
Years Active: 2026
Title: Mimi Guebre-xabier: Innovator in Immunology
Introduction
Mimi Guebre-xabier is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of immunology, particularly in the development of compositions and methods for inducing immune responses against influenza and coronaviruses. Her innovative work is crucial in the ongoing fight against viral infections.
Latest Patents
Mimi Guebre-xabier holds a patent for "Coronavirus and influenza compositions and methods for using them." This patent discloses compositions and methods designed to induce immune responses against both influenza and coronaviruses. The compositions include a coronavirus S (CoV S) glycoprotein in the form of a detergent-core nanoparticle, at least three hemagglutinin (HA) glycoproteins from different influenza strains, and a pharmaceutically acceptable buffer. This groundbreaking work has the potential to enhance vaccine efficacy and public health responses.
Career Highlights
Throughout her career, Mimi has focused on advancing the understanding of immune responses to viral pathogens. Her research has been instrumental in developing new strategies for vaccine design and implementation. With her innovative approach, she has positioned herself as a key figure in the field of immunology.
Collaborations
Mimi Guebre-xabier has collaborated with notable colleagues, including Nita Patel and Bin Zhou. These partnerships have fostered a collaborative environment that enhances research outcomes and accelerates the development of effective immunological solutions.
Conclusion
Mimi Guebre-xabier's contributions to immunology, particularly through her patent on coronavirus and influenza compositions, highlight her role as an innovative inventor. Her work not only advances scientific knowledge but also has the potential to impact public health significantly.